Andrew Spokes portfolio

Farallon Capital Management · Multi-strategy; founded by Tom Steyer

Farallon Capital Management's 13F filing for Q3 2026, filed with the SEC on November 16, 2026, reports $19.2B across 114 US-listed positions. The largest holding is RVMD at 14.4% of the portfolio; the ten largest make up 55%. The largest buy last quarter was Warner Bros Discovery Inc ($658.4M).

Reported value
$19.2B
Positions
114
In the top 10
55%
Quarter
Q3 2026
filed Nov 16

Key facts

13F portfolio value
$19.2BQ3 2026
Positions
114
Largest holding
RVMD 14.4%
Top 10 share
55%
New positions
48since Q2 2026
Sold out
23
Filed
Nov 16, 2026
Next 13F due
Feb 15, 2027Q4 2026

Holdings as of (Q3 2026), filed with the SEC on . Changes are measured against the filing for Jun 30, 2026. Source: SEC EDGAR, Form 13F-HR of Farallon Capital Management (CIK 909661).

Prices as of .

Compared with Q2 2026, Andrew Spokes opened 48 new positions (ROKU, CRH, Super Micro Computer Inc…), added to 25, trimmed 20, sold out of 23 (Electronic Arts Inc, Crinetics Pharmaceuticals, Apogee Therapeutics Inc…).

By sector, Health Care is the largest at 55% of the reported portfolio, followed by Technology at 7%; 22% is in securities with no sector on file.

31 of the 114 positions listed have been in every one of the last 9 quarterly filings.

Andrew Spokes top holdings: stocks in the Q3 2026 13F

Andrew Spokes holdings, Q3 2026
#StockSectorShare of portfolioValueSharesReported pricePrice nowSince period endHeldLast quarter
1Revolution Medicines IncRVMDHealth Care14.4%$2.8B13.42M$205.26$164.11 20.0% down9+ qtrs▼ Reduced 1.0%
2
Warner Bros Discovery Incno ticker on file
—7.96%$1.5B49.37M$30.95——4 qtrs▲ Added 76%
3Natera IncNTRAHealth Care5.60%$1.1B2.6M$413.31$282.29 31.7% down9+ qtrs▲ Added 17%
4Bridgebio Pharma IncBBIOHealth Care4.89%$937.5M14.25M$65.80$76.61 16.4% up9+ qtrs▲ Added 33%
5Protagonist Therapeutics IncPTGXHealth Care4.73%$907M6.44M$140.89$124.80 11.4% down9+ qtrs▲ Added 1.4%
6Exelixis IncEXELHealth Care4.47%$858.3M14.69M$58.41$67.99 16.4% up9+ qtrs▲ Added 9.1%
7Roivant Sciences LtdROIV · SHSHealth Care4.14%$795.2M21.75M$36.57$38.35 4.9% up9+ qtrs▲ Added 52%
8Roku IncROKUCommunication3.30%$633.5M4.16M$152.28$160.52 5.4% up1 qtrNew
9Amazon.com IncAMZNConsumer Discretionary3.08%$590.1M2.37M$249.15$256.64 3.0% up6 qtrs▼ Reduced 10%
10Grail IncGRALHealth Care2.97%$570.2M4.07M$140.12$105.21 24.9% down6 qtrs▼ Reduced 2.2%
11Boston Scientific CorpBSXHealth Care2.57%$492.7M11.29M$43.65$43.19 1.1% down9+ qtrs▲ Added 7.3%
12Broadcom IncAVGOTechnology2.56%$490.2M1.4M$351.19$339.84 3.2% down4 qtrs▲ Added 21%
13Crh PlcCRH · ORDMaterials2.31%$442.2M5.34M$82.80$91.84 10.9% up1 qtrNew
14Kenvue IncKVUE—2.30%$441.8M25.02M$17.66——4 qtrsNo change
15Twist Bioscience CorpTWSTHealth Care2.15%$412.8M2.14M$193.24$108.54 43.8% down9+ qtrsNo change
16UnitedHealth Group IncUNHHealth Care2.01%$384.9M1.05M$367.08$397.58 8.3% up9+ qtrs▼ Reduced 17%
17Microsoft CorpMSFTTechnology1.96%$376.2M733.56K$512.90$501.82 2.2% down9+ qtrs▼ Reduced 34%
18Synopsys IncSNPSTechnology1.95%$373.1M857.89K$434.94$434.70 0.1% down4 qtrs▲ Added 3.4%
19KKR & Co. IncKKRFinancials1.85%$354.2M3.88M$91.30$95.30 4.4% up4 qtrs▼ Reduced 5.8%
20Aon PLCAON · SHS CL AFinancials1.79%$343.1M1.24M$276.77$337.64 22.0% up9+ qtrs▼ Reduced 10%
21
Strategy Incno ticker on file · NOTE 12/0
—1.71%$328.2M————3 qtrs▲ Added 310%
22Lantheus Holdings IncLNTHHealth Care1.61%$309.7M3.11M$99.53$101.85 2.3% up9+ qtrs▼ Reduced 44%
23Thermo Fisher Scientific IncTMOHealth Care1.57%$300.9M445.69K$675.05$691.69 2.5% up9+ qtrs▼ Reduced 58%
24Liquidia CorporationLQDA—1.40%$269.5M8.91M$30.26$56.02 85.1% up9+ qtrs▲ Added 6.5%
25WabtecWABIndustrials1.31%$252.1M877.9K$287.18$292.65 1.9% up9+ qtrs▼ Reduced 1.9%
26Beam Therapeutics IncBEAM—1.31%$251.3M10.28M$24.45$20.88 14.6% down9+ qtrs▲ Added 0.4%
27AramarkARMKConsumer Discretionary1.29%$246.7M4.61M$53.55$56.90 6.3% up9+ qtrs▲ Added 27%
28Immunovant IncIMVTHealth Care1.14%$218.6M6.47M$33.78$33.31 1.4% down9+ qtrs▲ Added 11%
29Agios Pharmaceuticals IncAGIO—1.03%$197.5M5.94M$33.25$29.34 11.8% down9+ qtrs▲ Added 0.4%
30Biogen IncBIIBHealth Care0.80%$153.8M680.87K$225.88$250.96 11.1% up2 qtrs▲ Added 859%
31
Super Micro Computer Incno ticker on file · NOTE 3.500% 3/0
—0.79%$151.7M————1 qtrNew
32Johnson & JohnsonJNJHealth Care0.66%$127.2M480.43K$264.74$280.51 6.0% up3 qtrs▲ Added 18%
33Acadia Healthcare CompanyACHC—0.66%$126.7M4.61M$27.50$38.44 39.8% up3 qtrs▲ Added 9.2%
34Brightspring Health Services IncBTSGHealth Care0.60%$116M2.04M$56.75$69.85 23.1% up9+ qtrs▲ Added 18%
35Tango Therapeutics IncTNGX—0.59%$113.5M4.55M$24.95$22.54 9.7% down8 qtrs▼ Reduced 63%
36Baidu IncBIDU · SPON ADR REP ATechnology0.55%$104.6M1.2M$86.87$71.63 17.5% down5 qtrsNo change
37American Savings Bank NAASBH—0.43%$81.5M4.56M$17.89$21.56 20.5% up1 qtrNew
38Parabilis Medicines IncPBLS—0.40%$76.5M2.37M$32.29$28.05 13.1% down2 qtrsNo change
39AstraZeneca PLCAZN · ORDHealth Care0.37%$71M440K$161.47$183.33 13.5% up3 qtrs▼ Reduced 23%
40JOYY IncJOYY · ADS REPSTG COM A—0.34%$65.8M820.2K$80.25$79.06 1.5% down7 qtrs▲ Added 17%
41Avalo Therapeutics IncAVTX—0.32%$60.9M3.97M$15.33$6.99 54.4% down3 qtrs▲ Added 59%
42Freenome IncFRNM—0.31%$58.8M3.73M$15.75$9.99 36.6% down1 qtrNew
43Ionic Digital IncIOND—0.30%$57.7M718.12K$80.33$61.87 23.0% down1 qtrNew
44Guardant Health IncGHHealth Care0.26%$49.9M279.7K$178.36$143.37 19.6% down6 qtrs▼ Reduced 13%
45
Strategy Incno ticker on file · NOTE 3/0
—0.24%$45.1M————2 qtrs▲ Added more than 10×
46Assembly Biosciences IncASMB—0.20%$37.7M1.6M$23.49$22.00 6.3% down5 qtrsNo change
47Novartis AGNVS · SPONSORED ADRHealth Care0.19%$36.4M255K$142.57$159.81 12.1% up2 qtrs▼ Reduced 30%
48Maze Therapeutics IncMAZE—0.16%$30.1M1.11M$27.18$33.08 21.7% up3 qtrsNo change
49LB Pharmaceuticals IncLBRX—0.15%$28.5M741.41K$38.38$39.91 4.0% up1 qtrNew
50Immunocore Holdings plcIMCR · ADS—0.15%$28.1M928K$30.29$27.91 7.9% down1 qtrNew
51ASML Holding NVASML · N Y REGISTRY SHSTechnology0.13%$24.5M13.52K$1,811.67$1,364.11 24.7% down1 qtrNew
52Rio Tinto PLCRIO · SPONSORED ADRMaterials0.11%$20.6M218.9K$94.17$79.96 15.1% down3 qtrs▲ Added 19%
53Alibaba Group Holding LtdBABA · SPONSORED ADSConsumer Discretionary0.11%$20.3M189K$107.54$86.99 19.1% down1 qtrNew
54Electra Therapeutics IncETRA—0.10%$19.1M1.7M$11.25$8.53 24.2% down1 qtrNew
55Alvotech SAALVO · ORDINARY SHARES—0.09%$16.6M2.86M$5.80$4.30 25.9% down9+ qtrsNo change
56Indivior Pharmaceuticals IncSUPN—0.08%$16M447.62K$35.85$29.14 18.7% down1 qtrNew
57Alamar Biosciences IncALMR—0.08%$15.8M462.9K$34.07$30.50 10.5% down2 qtrsNo change
58NetEase IncNTES · SPONSORED ADSTechnology0.08%$15M123.5K$121.16$119.97 1.0% down3 qtrsNo change
59Latigo Biotrapeutics IncLTGO—0.07%$14.2M850K$16.70$13.18 21.1% down1 qtrNew
60Abivax SAABVX · SPONSORED ADSHealth Care0.07%$13.9M140K$99.02$82.95 16.2% down5 qtrs▲ Added 15%
61Kailera Therapeutics IncKLRA—0.07%$12.6M1.1M$11.42$12.28 7.5% up2 qtrsNo change
62Enanta Pharmaceuticals IncENTA—0.07%$12.5M950K$13.18$8.89 32.6% down9+ qtrs▼ Reduced 61%
63Vnet Group IncVNET · SPONSORED ADS A—0.06%$11.2M2.03M$5.55$2.57 53.7% down9+ qtrs▲ Added 1.7%
64Taysha Gene Therapies IncTSHA—0.06%$11M2.25M$4.87$4.01 17.7% down2 qtrs▼ Reduced 0.04%
65Minerva Neurosciences IncNERV—0.04%$7.9M2.37M$3.35$2.13 36.4% down4 qtrsNo change
66Scribe Therapeutics IncSCTX—0.04%$7M380K$18.41$15.59 15.3% down1 qtrNew
67Cohu IncCOHU—0.03%$6.2M91K$68.14$39.88 41.5% down1 qtrNew
68Inflarx NVIFRX—0.03%$6M3.31M$1.80$1.14 36.7% down2 qtrs▼ Reduced 0.5%
69
Super Micro Computer Incno ticker on file · NOTE 2.250% 7/1
—0.03%$5.9M————1 qtrNew
70Entegris IncENTGMaterials0.03%$5.7M37K$154.06$142.16 7.7% down1 qtrNew
71Braveheart Bio IncBRVE—0.03%$5.6M277.78K$20.20$18.88 6.5% down1 qtrNew
72Celestica IncCLSTechnology0.03%$5.4M15K$361.43$235.79 34.8% down1 qtrNew
73Revvity IncRVTYHealth Care0.03%$5.4M35K$152.89$150.47 1.6% down1 qtrNew
74Veeva Systems IncVEEV · CL A COMTechnology0.03%$5.3M18.5K$285.45$293.18 2.7% up1 qtrNew
75Rockwell Automation IncROKIndustrials0.03%$5.2M12K$435.33$390.79 10.2% down1 qtrNew
76Gates IndustrialGTESIndustrials0.03%$5.1M196K$26.20$24.86 5.1% down1 qtrNew
77Mcgraw Hill IncMH—0.03%$5.1M389K$13.11$11.45 12.7% down1 qtrNew
78Ecolab IncECLMaterials0.03%$5.1M18.5K$274.58$308.44 12.3% up1 qtrNew
79Worthington Enterprises IncWOR—0.03%$5.1M85K$59.54$57.80 2.9% down1 qtrNew
80Ati IncATIMaterials0.03%$5M26.5K$189.40$171.84 9.3% down1 qtrNew
81Builders Firstsource IncBLDRConsumer Discretionary0.03%$5M87K$57.01$59.94 5.1% up1 qtrNew
82Nike IncNKE · CL BConsumer Discretionary0.03%$5M140K$35.40$37.80 6.8% up1 qtrNew
83RPM International IncRPMMaterials0.03%$4.9M50K$98.67$104.69 6.1% up1 qtrNew
84
Companhia Paranaense de Enerno ticker on file · SPONSORED ADS
—0.03%$4.9M395K$12.42——1 qtrNew
85Magna International IncMGAConsumer Discretionary0.03%$4.9M77K$63.67$62.51 1.8% down1 qtrNew
86Woodside Energy Group LtdWDS · SPONSORED ADR—0.03%$4.9M220K$22.17$20.47 7.7% down1 qtrNew
87Modine Manufacturing CoMODConsumer Discretionary0.03%$4.9M26K$187.20$128.65 31.3% down1 qtrNew
88Factset Resh Systems IncFDSTechnology0.03%$4.9M18K$269.95$319.67 18.4% up1 qtrNew
89Nextpower IncNXTTechnology0.03%$4.8M62K$77.93$84.01 7.8% up1 qtrNew
90Vesta Real Estate CorpVTMX · ADS—0.03%$4.8M150K$32.18$37.36 16.1% up1 qtrNew
91Expeditors International Wash IncEXPDIndustrials0.03%$4.8M26K$184.64$192.40 4.2% up1 qtrNew
92Gxo Logistics IncorporatedGXOIndustrials0.03%$4.8M108K$44.45$56.95 28.1% up1 qtrNew
93KBR IncKBRIndustrials0.03%$4.8M136K$35.16$35.32 0.5% up1 qtrNew
94Flex LtdFLEX · ORDTechnology0.03%$4.7M43K$109.99$72.61 34.0% down1 qtrNew
95Guidewire Software IncGWRETechnology0.03%$4.7M33K$142.58$146.04 2.4% up1 qtrNew
96Kraft Heinz CoKHCConsumer Staples0.02%$4.7M206K$22.72$25.36 11.6% up1 qtrNew
97Compania de Minas BuenaventuBVN · SPONSORED ADRMaterials0.02%$4.7M148K$31.58$23.46 25.7% down1 qtrNew
98Lemonade IncLMND—0.02%$4.6M103K$45.14$42.20 6.5% down1 qtrNew
99Telix Pharmaceutical LtdTLX · SPONSORED ADS—0.02%$4.6M419K$10.97$8.90 18.8% down1 qtrNew
100Mobia Med IncMOBI—0.02%$4.1M437.83K$9.45$12.62 33.5% up2 qtrs▼ Reduced 61%
101Sagimet Biosciences IncSGMT—0.02%$4M400K$9.88$9.91 0.3% up2 qtrs▼ Reduced 3.6%
102Jatt III Acquisition CorpJTTT · ORD SHS—0.02%$3.9M350K$11.16$10.23 8.3% down1 qtrNew
103Goosehead Insurance IncGSHD—0.02%$3.8M84K$45.36$49.80 9.8% up1 qtrNew
104Prime Medicine IncPRME—0.02%$3.8M1.24M$3.05$4.09 33.9% up9+ qtrsNo change
105Jatt II Acquisition CorpJATT · ORD SHS—0.02%$3.3M300K$11.12$10.20 8.3% down2 qtrsNo change
106Summit Midstream CorporationSMC—0.01%$1.8M58.21K$30.23$30.53 1.0% up9+ qtrsNo change
107
Revolution Medicines Incno ticker on file · *W EXP 12/17/202
—0.01%$1.4M120.09K$11.46——9+ qtrsNo change
108Cogent Biosciences IncCOGTHealth Care0.00%$544.3K17K$32.02$27.07 15.5% down9+ qtrsNo change
109Welltower IncWELLReal Estate0.00%$230.2K1K$230.24$242.74 5.4% up4 qtrsNo change
110Pacific Biosciences of California IncPACB—0.00%$33.7K14.2K$2.37$1.83 23.0% down9+ qtrsNo change
111Geron CorpGERN—0.00%$17.7K14.4K$1.23$0.9778 20.5% down9+ qtrsNo change
112Rani Therapeutics Holdings-ARANI—0.00%$16.4K20.7K$0.7910$0.5700 27.9% down4 qtrsNo change
113Canopy Growth CorporationCGC—0.00%$16.1K18K$0.8962$0.5378 40.0% down9+ qtrsNo change
114
Nvni Group Limitedno ticker on file · *W EXP 11/01/202
—0.00%$5.7K331.4K$0.0172——9+ qtrs▼ Reduced 12%

Andrew Spokes latest buys (Q3 2026)

  • Warner Bros Discovery Inc ▲ Added 76%$658.4M
  • ROKU New$633.5M
  • CRH New$442.2M
  • ROIV ▲ Added 52%$272M
  • Strategy Inc ▲ Added 310%$248.2M
  • BBIO ▲ Added 33%$230.6M
  • NTRA ▲ Added 17%$157.6M
  • Super Micro Computer Inc New$151.7M
  • BIIB ▲ Added 859%$137.8M
  • AVGO ▲ Added 21%$85.7M

Andrew Spokes latest sells (Q3 2026)

  • Electronic Arts Inc Sold$1.6B
  • TMO ▼ Reduced 58%$407.4M
  • Crinetics Pharmaceuticals Sold$336.4M
  • LNTH ▼ Reduced 44%$246.1M
  • MSFT ▼ Reduced 34%$194.5M
  • TNGX ▼ Reduced 63%$192.7M
  • Apogee Therapeutics Inc Sold$140.7M
  • NVO Sold$125.6M
  • UNH ▼ Reduced 17%$81.5M
  • AMZN ▼ Reduced 10%$65.9M

Every buy and sell in Andrew Spokes' Q3 2026 13F →

By sector

Andrew Spokes portfolio by sector, Q3 2026
SectorShare of portfolioValuePositions
Health Care55.2%$10.6B22
Technology7.37%$1.4B12
Consumer Discretionary4.57%$876.8M7
Financials3.63%$697.3M2
Communication3.30%$633.5M1
Materials2.54%$488.3M7
Industrials1.44%$276.9M6
Consumer Staples0.02%$4.7M1
Real Estate0.00%$230.2K1
No sector on file21.9%$4.2B55

8 quarterly filings on file for Farallon Capital Management, back to Q4 2024: reported value, position counts, and every buy and sell quarter by quarter.

Filing history →All Q3 2026 13F filings →

Questions about Andrew Spokes' portfolio

What stocks does Andrew Spokes own?

According to Farallon Capital Management's 13F filing for Q3 2026, the largest of its 114 US-listed positions are RVMD (14.4%), Warner Bros Discovery Inc (8.0%), NTRA (5.6%), BBIO (4.9%) and PTGX (4.7%). A 13F shows long positions only, as of the quarter's end.

What is Andrew Spokes' largest holding?

RVMD (Revolution Medicines Inc), worth $2.8B at the end of Q3 2026, or 14.4% of the $19.2B Farallon Capital Management reported.

What did Andrew Spokes buy last quarter?

In Q3 2026, compared with the filing for Q2 2026, the largest purchases were Warner Bros Discovery Inc (added, $658.4M), ROKU (new position, $633.5M), CRH (new position, $442.2M), ROIV (added, $272M) and Strategy Inc (added, $248.2M).

What did Andrew Spokes sell last quarter?

In Q3 2026 the largest sales were Electronic Arts Inc (sold out, $1.6B), TMO (reduced, $407.4M), Crinetics Pharmaceuticals (sold out, $336.4M), LNTH (reduced, $246.1M) and MSFT (reduced, $194.5M), against the filing for Q2 2026.

How much is Andrew Spokes' portfolio worth?

Farallon Capital Management reported $19.2B in 114 US-listed positions for Q3 2026, valued at the quarter's end and filed on November 16, 2026. That is the 13F portfolio only: no cash, short positions or most shares listed outside the US.

When does Andrew Spokes file the next 13F?

The 13F for Q4 2026, the quarter ending December 31, 2026, is due by February 15, 2027: 45 days after the quarter ends, or the next business day. The latest filing on file here is for Q3 2026, filed on November 16, 2026.

Which sectors does Andrew Spokes own?

Health Care 55.2%, Technology 7.4%, Consumer Discretionary 4.6%, Financials 3.6%, Communication 3.3% of the reported portfolio, with 21.9% in securities that have no sector on file here (funds, smaller companies, positions without a ticker).

How long has Andrew Spokes held these stocks?

Counting consecutive quarterly filings up to Q3 2026: RVMD 9+, Warner Bros Discovery Inc 4, NTRA 9+, BBIO 9+, PTGX 9+, EXEL 9+. “9+” means the position is in every filing looked at, so it may go back further.

Learn

Cite this page

Funkfolio, “Andrew Spokes portfolio: Farallon Capital Management 13F holdings (Q3 2026)”, data as of 16 November 2026. https://funkfolio.com/gurus/farallon

Underlying data: SEC EDGAR, Form 13F-HR of Farallon Capital Management (CIK 909661) for the period ending September 30, 2026.

Source: SEC EDGAR, Form 13F-HR for Farallon Capital Management (CIK 909661), period ending Sep 30, 2026, filed Nov 16, 2026. “Last quarter” compares share counts with the filing for Jun 30, 2026. 2 option positions in the filing are not shown. “Reported price” is the position's reported value divided by its shares — the price the filing implies for the period end. “Price now” is from Yahoo Finance and can be delayed 15 minutes or more; “since period end” sets the two side by side and is left blank where the reported price falls outside the stock's 52-week range, which points to a share split since. A split small enough to stay inside that range is not caught, and dividends are not counted. Sectors are those of the ranked companies on this site; funds, smaller companies and positions without a ticker have none. “Held” counts consecutive quarterly filings the position appears in, out of the 9 looked at. A buy or sell is sized as the shares moved at the price the filing implies; a position sold out at its value in the previous filing. Filings can be 45 days old when published; this is not a live portfolio and not advice.